Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases

Giuseppe Legname, Tommaso Virgilio, Edoardo Bistaffa, Chiara Maria Giulia De Luca, Marcella Catania, Paola Zago, Elisa Isopi, Ilaria Campagnani, Fabrizio Tagliavini, Giorgio Giaccone, Fabio Moda

Research output: Contribution to journalArticlepeer-review


Pin1 is a peptidyl-prolyl isomerase that induces the cis-trans conversion of specific Ser/Thr-Pro peptide bonds in phosphorylated proteins, leading to conformational changes through which Pin1 regulates protein stability and activity. Since down-regulation of Pin1 has been described in several neurodegenerative disorders, including Alzheimer's Disease (AD), Parkinson's Disease (PD) and Huntington's Disease (HD), we investigated its potential role in prion diseases. Animals generated on wild-type (Pin1+/+), hemizygous (Pin1+/−) or knock-out (Pin1−/−) background for Pin1 were experimentally infected with RML prions. The study indicates that, neither the total depletion nor reduced levels of Pin1 significantly altered the clinical and neuropathological features of the disease.

Original languageEnglish
Pages (from-to)127-137
Number of pages11
Issue number2
Publication statusPublished - Mar 4 2018


  • neurodegeneration
  • Pin1
  • PMCA
  • prion

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Infectious Diseases


Dive into the research topics of 'Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases'. Together they form a unique fingerprint.

Cite this